Company Filing History:
Years Active: 1986-1987
Title: **John P Montgomery: Innovator in Phenylalanine Production**
Introduction
John P Montgomery, based in Clarksburg, Maryland, is an inventive mind known for his contributions to biotechnology. With a total of two patents to his name, Montgomery focuses on advancements in microbial strains and enzymatic processes that significantly enhance the production of L-phenylalanine, a critical amino acid.
Latest Patents
Montgomery's innovative work includes his latest patent on **Phenylalanine ammonia lyase-producing microbial cells**. This invention highlights novel microbial strains that have the capability to grow on minimal essential media utilizing L-tyrosine as their primary carbon source. The patent also details methods for producing phenylalanine ammonia-lyase and the subsequent conversion into L-phenylalanine. Additionally, another significant patent pertains to a **method for stabilizing the enzymatic activity of phenylalanine ammonia**. This method describes an enzymatic conversion process of t-cinnamic acid and ammonia to L-phenylalanine, utilizing the catalyst phenylalanine ammonia-lyase, while improving the enzyme's stability and lifespan through anaerobic static conditions.
Career Highlights
John P Montgomery is currently affiliated with Genex Corporation, where he contributes to research and development within the field of biotechnology. His expertise has played a pivotal role in advancing biotechnological applications that have the potential to influence various industries.
Collaborations
Throughout his career, Montgomery has collaborated with esteemed colleagues such as Huei-Hsuing Yang and Patricia J Vollmer. These collaborations reflect a commitment to teamwork and innovation, enhancing the outcomes of their research initiatives.
Conclusion
In summary, John P Montgomery stands out as an important figure in the realm of biotechnology, particularly in the development of methods and strains for L-phenylalanine production. His work not only showcases his inventive capabilities but also highlights the collaborative spirit that drives scientific progress in addressing complex challenges in the biotechnology sector.